...
首页> 外文期刊>Frontiers in Psychiatry >Educational and Behavioral Counseling in a Methadone Maintenance Treatment Program in China: A Randomized Controlled Trial
【24h】

Educational and Behavioral Counseling in a Methadone Maintenance Treatment Program in China: A Randomized Controlled Trial

机译:美沙酮维持治疗计划中的教育和行为咨询:一项随机对照试验

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Introduction Methadone maintenance treatment (MMT) programs have been rapidly scaled up nationwide in China in recent years, and psychosocial intervention measures, including counseling, were recommended for improving the outcomes of MMT. However, the effectiveness of counseling in MMT programs remains controversial. This study investigated the efficacy of educational and behavioral counseling (EBC) mode in an MMT program in China. Methods A total of 125 eligible participants were randomized to EBC or a control group. Patients in the EBC group received weekly, manual-guided, group educational counseling for 8?weeks and individual behavioral counseling for the next 8?weeks. Patients in the control group received standard methadone maintenance treatment as usual (TAU). Results During the 16-week trial, the EBC group showed better treatment attendance ( P ?=?0.022) and a greater increase in knowledge regarding heroin addiction ( P ?=?0.001) and MMT ( P ?=?0.005) than did the TAU group. Between the two groups, there were no significant differences regarding drug abstinence and reduction of risky behaviors. Conclusion EBC affiliated with MMT improved patients’ cognition and adherence to treatment, facilitating their successful recovery. Clinical Trial Registration ChiCTR-IOR-15006673: http://www.chictr.org.cn .
机译:简介近年来,美沙酮维持治疗(MMT)计划已在中国全国范围内迅速扩大,并建议采取心理社会干预措施(包括咨询)来改善MMT的疗效。但是,MMT计划中咨询的有效性仍然存在争议。这项研究调查了中国MMT计划中的教育和行为咨询(EBC)模式的功效。方法将125名符合条件的参与者随机分为EBC组或对照组。 EBC组的患者每周接受为期8周的手动指导,团体教育咨询,并在接下来的8周内接受个人行为咨询。对照组患者照常接受标准美沙酮维持治疗(TAU)。结果在16周的试验中,EBC组的治疗出席率(P = 0.02)和对海洛因成瘾的了解增加了(P = 0.001)和MMT的知识增加了(P = 0.005)。 TAU集团。两组之间在戒毒和减少危险行为方面没有显着差异。结论与MMT相关的EBC可以提高患者的认知度和对治疗的依从性,有助于患者成功康复。临床试验注册ChiCTR-IOR-15006673:http://www.chictr.org.cn。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号